Clinical Updates: Management of Vertebral Compression Fractures in Primary Care
While pain from vertebral compression fractures usually resolves spontaneously without treatment, some patients suffer debilitating pain despite optimal nonsurgical care. In these individuals, minimally invasive percutaneous vertebral augmentation can offer relief. The two most widely performed augmentation procedures are vertebroplasty and balloon kyphoplasty. Both techniques use bone cement to stabilize crushed vertebral bone and, in the case of kyphoplasty, to restore a measure of vertebral height lost to compression. Fee: Member- $0; Nonmember-$10
Initial Date: December 1, 2019
Expiration Date: December 31, 2021
Credits Available: 1 hour
Fee: Members-$0; Nonmembers- $10

Disclosures:
-Angelo Licata, MD, PhD: Nothing to Disclose
-Mary Beth O'Connell, PharmD, BCPS: Honorarium-American Society of Consultant Pharmacists
-Adrienne Berarducci, PhD, ARNP, BC: Nothing to Disclose
-Peggy Doheny, PhD, RN: Nothing to Disclose
-Avery Jackson, MD: Nothing to Disclose
-Craig Langman, MD: Consultant-Dicerna Pharma, Incyte Pharma, and Allena Pharma
-Jeri Nieves, PhD: Grant/Research-Eli Lilly
-Rick Pope, MPAS, PA-C: Nothing to Disclose
-Susan Randall, MSN, RN, FNP-BC: Nothing to Disclose
-Carol Sedlack, PhD, RN: Nothing to Disclose
-Andrea Sikon, MD: Nothing to Disclose
-Andrea Singer, MD: Research-Radius Health, UCB; Consulting-Agnovos, Amgen, Eli Lilly, Merit, Radius Health, UCB; Speaker's Bureau-Amgen, Eli Lilly, Radius Health; Board-NOF
-Kelly Trippe, MA: Nothing to Disclose
-Robert Westergan, MD: Nothing to Disclose

Support for this activity was received from Medtronic.

Activity Description
While pain from vertebral compression fractures usually resolves spontaneously without treatment, some patients suffer debilitating pain despite optimal nonsurgical care. In these individuals, minimally invasive percutaneous vertebral augmentation can offer relief. The two most widely performed augmentation procedures are vertebroplasty and balloon kyphoplasty. Both techniques use bone cement to stabilize crushed vertebral bone and, in the case of kyphoplasty, to restore a measure of vertebral height lost to compression. 

In this issue of Osteoporosis: Clinical Updates we will examine primary care management of VCF and the pain that can result. We will discuss effective pain control for new and recent fractures and for the potential consequences of multiple fractures. In the process, we provide a framework for patient-centered clinical decision making.

Intended Audience
This continuing education activity is intended for use by health professionals who participate in the care of patients at risk for or suffering from osteoporosis, in the areas of primary care, endocrinology, geriatrics, gynecology, internal medicine, obstetrics, orthopedics, osteopathy, pediatrics, physiatry, radiology, rheumatology and physical therapy.

This includes physicians, nurse practitioners, registered nurses, pharmacists, physician assistants, technologists, researchers, public health professionals and health educators with an interest in osteoporosis and bone health.


Objectives
Upon completion of this activity the participant should be able to:

1) Help individual patients weigh the pros and cons of various pain control medications for symptomatic vertebral compression fractures.


2) Educate patients regarding effective non-pharmacologic therapies for controlling pain from vertebral compression fractures.
3) Apply appropriateness criteria to identify patients suitable for advanced imaging, minimally invasive vertebral augmentation, and/or referral to specialty pain clinic.
4) Create a comprehensive bone health and symptom management plan for patients with kyphosis from multiple vertebral fractures.
5) Discuss the risks and benefits of vertebroplasty and kyphoplasty for individual patients.

CME Program Eligibility
Method of Participation in the Learning Process: Clinician learners will read and analyze the subject matter, conduct additional informal research through related internet searches on the subject matter, and complete a post-test assessment of knowledge and skills gained as a result of the activity.

After participating in this activity, the reader has the option of taking a post-test with a passing grade of 70% or better to qualify for continuing education credit for this activity. It is estimated it will take 1.0 hour(s) to complete the reading and take the post-test. Continuing education credit will be available for two years from the date of publication.


Accreditation

The National Osteoporosis Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The National Osteoporosis Foundation designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

The National Osteoporosis Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. The National Osteoporosis Foundation designates this educational activity for a maximum of 1.0 continuing nursing education credit(s).

Other healthcare providers will also be able to receive a certificate of completion; nurse practitioners and physician assistants may request an AMA PRA Category 1 Credit(s)™ certificate of participation.


Disclosure of Commercial Support

It is the policy of the National Osteoporosis Foundation (NOF) to ensure balance, independence, objectivity, and scientific rigor in all its sponsored publications and programs. NOF requires the disclosure of the existence of any significant financial interest or any other relationship the sponsor, Editorial Board or Guest Contributors have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. All authors and contributors to this continuing education activity have disclosed any real or apparent interest that may have direct bearing on the subject matter of this program.

Please be advised that NOF’s accreditation status with ACCME and ANCC does not imply endorsement by NOF, ACCME or ANCC of any commercial products displayed in conjunction with this activity or endorsement of any point of view.


Statement regarding OFF Label Use

Please be advised that any publication of the Osteoporosis Clinical Updates that discusses off-label use of any medications or devices will be disclosed to the participant.

Refund Policy
NOF offers no returns or refunds on online internet CME activities purchased through our store. All sales are final. Meeting and workshop registrations will be refunded in accordance with the cancellation policy of the meeting and/or workshop, as outlined at registration.



Type:     Internet Activity (Enduring Material)
8 Registered Users

National Osteoporosis Foundation

251 18th Street South, Suite 630, Arlington, VA 22202 I [p] 1 (800) 231-4222 • [f] 1 (703) 414-3742

The National Osteoporosis Foundation is a qualified 501(c)(3) tax-exempt organization and all donations to the organization are
tax deductible to the full extent allowable by law. NOF’s tax ID number is 36-3350532.